• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cost-effectiveness of HCC surveillance among HCV patients after sustained virological response with direct-acting antivirals.

作者信息

Huang Daniel Q, Nguyen Mindie H

机构信息

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Division of Gastroenterology and Hepatology, National University Health System, Singapore.

出版信息

Liver Int. 2021 Dec;41(12):3036-3037. doi: 10.1111/liv.15072. Epub 2021 Oct 5.

DOI:10.1111/liv.15072
PMID:34587343
Abstract
摘要

相似文献

1
Cost-effectiveness of HCC surveillance among HCV patients after sustained virological response with direct-acting antivirals.
Liver Int. 2021 Dec;41(12):3036-3037. doi: 10.1111/liv.15072. Epub 2021 Oct 5.
2
The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?接受新型直接抗病毒药物治疗的患者实现持续病毒学应答后发生肝细胞癌的风险：我们应该为此担忧吗？
Expert Rev Anti Infect Ther. 2016 Nov;14(11):993-996. doi: 10.1080/14787210.2016.1243466.
3
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.直接作用抗病毒药物治疗的 HCV 患者中 HCC 早期发生的发生率和风险因素：一项前瞻性多中心研究。
J Transl Med. 2019 Aug 28;17(1):292. doi: 10.1186/s12967-019-2033-x.
4
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis.丙型肝炎病毒感染和高级纤维化患者治疗后持续病毒学应答的肝细胞癌监测的成本效益。
Clin Gastroenterol Hepatol. 2019 Aug;17(9):1840-1849.e16. doi: 10.1016/j.cgh.2018.12.018. Epub 2018 Dec 20.
5
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.AGA 临床实践更新：口服直接作用抗病毒药物治疗慢性丙型肝炎感染与肝细胞癌的相互作用：专家综述。
Gastroenterology. 2019 Jun;156(8):2149-2157. doi: 10.1053/j.gastro.2019.02.046. Epub 2019 Mar 13.
6
Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.在丙型肝炎感染且伴有严重肝纤维化的患者中，对直接抗病毒药物产生持续病毒学应答后，人类免疫缺陷病毒（HIV）感染与肝细胞癌风险降低相关。
Clin Infect Dis. 2021 Oct 5;73(7):e2109-e2116. doi: 10.1093/cid/ciaa1111.
7
Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?丙型肝炎病毒纤维化进展后病毒应答后肝细胞癌风险：谁需要筛查，需要筛查多久？
World J Gastroenterol. 2021 Oct 28;27(40):6737-6749. doi: 10.3748/wjg.v27.i40.6737.
8
Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents.直接作用抗病毒药物治疗的严重纤维化或肝硬化丙型肝炎患者发生肝细胞癌和纤维化进展的风险。
Acta Gastroenterol Belg. 2021 Jan-Mar;84(1):25-32. doi: 10.51821/84.1.420.
9
Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.慢性丙型肝炎病毒感染患者持续病毒学应答后肝癌发生的分子机制。
Viruses. 2018 Sep 28;10(10):531. doi: 10.3390/v10100531.
10
Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma.直接作用抗病毒药物可使慢性丙型肝炎感染和肝细胞癌患者产生良好的、持续的病毒学应答。
Korean J Intern Med. 2021 Mar;36(2):286-287. doi: 10.3904/kjim.2021.078. Epub 2021 Feb 25.